imaging
GE HealthCare Joins EU Theranostics Consortium to Advance Radiopharmaceutical Development, Access
The new consortium, dubbed Thera4Care, launched with €25.3 million in EU government funding and 29 academic and industry partners.
The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research validates findings from this small study.
FDA Allowing Compassionate Use Access to Telix's Glioma PET Imaging Agent
Telix will seek FDA approval to sell TLX101-CDx as an imaging agent for advanced glioma patients.
Telix Files for FDA Approval for New PSMA-PET Imaging Agent TLX007-CDx
The firm already markets a radiopharmaceutical companion diagnostic for Pluvicto but is hoping to improve patient access with this new imaging agent.
Researchers at ASCO presented data on the genomic differences in tumors based on IHC and imaging, between racial groups, and between primary and metastatic lesions.